Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow-to-Debt Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd cash flow-to-debt ratio. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of CN¥1.84 Billion could theoretically repay 0% of its total liabilities (CN¥43.39 Billion) in one year. Check 600332 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Cash flow-to-debt ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. Historical debt coverage capacity for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. Check Guangzhou Baiyunshan Pharmaceutical Hold (600332) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow-to-Debt Ratio by Year (2000–2025)
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd cash flow-to-debt ratio by year from 2000 to 2025. Year-by-year debt coverage analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For the full cash flow conversion analysis, see Guangzhou Baiyunshan Pharmaceutical Hold operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | CN¥260.23 Million | CN¥43.39 Billion | ▼ -92.3% |
| 2024 | 0.08x | CN¥3.44 Billion | CN¥43.91 Billion | ▼ -19.9% |
| 2023 | 0.10x | CN¥4.10 Billion | CN¥41.91 Billion | ▼ -42.6% |
| 2022 | 0.17x | CN¥7.00 Billion | CN¥41.03 Billion | ▲ +4.6% |
| 2021 | 0.16x | CN¥5.67 Billion | CN¥34.79 Billion | ▲ +779.3% |
| 2020 | 0.02x | CN¥585.19 Million | CN¥31.55 Billion | ▼ -88.6% |
| 2019 | 0.16x | CN¥5.02 Billion | CN¥30.90 Billion | ▼ -11.7% |
| 2018 | 0.18x | CN¥5.22 Billion | CN¥28.34 Billion | ▼ -9.1% |
| 2017 | 0.20x | CN¥1.83 Billion | CN¥9.05 Billion | ▼ -31.7% |
| 2016 | 0.30x | CN¥2.44 Billion | CN¥8.24 Billion | ▲ +9.7% |
| 2015 | 0.27x | CN¥1.94 Billion | CN¥7.19 Billion | ▼ -4.1% |
| 2014 | 0.28x | CN¥1.76 Billion | CN¥6.25 Billion | ▲ +10.0% |
| 2013 | 0.26x | CN¥1.34 Billion | CN¥5.23 Billion | ▲ +1.7% |
| 2012 | 0.25x | CN¥506.53 Million | CN¥2.01 Billion | ▲ +233.7% |
| 2011 | -0.19x | CN¥-180.05 Million | CN¥956.09 Million | ▼ -314.9% |
| 2010 | 0.09x | CN¥73.17 Million | CN¥835.05 Million | ▼ -83.6% |
| 2009 | 0.54x | CN¥439.39 Million | CN¥820.92 Million | ▲ +7845.1% |
| 2008 | 0.01x | CN¥6.10 Million | CN¥905.99 Million | ▼ -94.8% |
| 2007 | 0.13x | CN¥375.74 Million | CN¥2.91 Billion | ▲ +714.6% |
| 2006 | 0.02x | CN¥38.88 Million | CN¥2.46 Billion | ▼ -75.2% |
| 2005 | 0.06x | CN¥146.32 Million | CN¥2.29 Billion | ▼ -18.9% |
| 2004 | 0.08x | CN¥200.54 Million | CN¥2.55 Billion | ▲ +2533.8% |
| 2003 | 0.00x | CN¥-6.83 Million | CN¥2.11 Billion | ▼ -103.4% |
| 2002 | 0.10x | CN¥169.01 Million | CN¥1.75 Billion | ▼ -2.6% |
| 2001 | 0.10x | CN¥140.15 Million | CN¥1.41 Billion | ▼ -45.9% |
| 2000 | 0.18x | CN¥286.95 Million | CN¥1.57 Billion | — |